Allurion Technologies (NYSE:ALUR) Posts Quarterly Earnings Results, Misses Expectations By $2.00 EPS

Allurion Technologies (NYSE:ALUR) issued its earnings results on Wednesday. The company reported ($7.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($5.00) by ($2.00), Zacks reports. The company had revenue of $5.59 million during the quarter, compared to the consensus estimate of $5.60 million. Allurion Technologies updated its FY 2025 guidance to EPS.

Allurion Technologies Stock Up 4.1 %

Shares of NYSE:ALUR opened at $3.25 on Friday. The firm has a fifty day simple moving average of $4.01 and a two-hundred day simple moving average of $9.84. The stock has a market capitalization of $15.57 million, a P/E ratio of -0.27 and a beta of -0.59. Allurion Technologies has a 52 week low of $2.15 and a 52 week high of $98.75.

Analysts Set New Price Targets

ALUR has been the topic of several research analyst reports. Chardan Capital reissued a “neutral” rating and issued a $2.50 target price on shares of Allurion Technologies in a report on Thursday. Roth Mkm reiterated a “buy” rating and issued a $16.00 price target on shares of Allurion Technologies in a research note on Friday, March 21st.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.